Valuation: EBOS Group Limited

Market Cap 366.54Cr 449.13Cr 251.02Cr 225.12Cr 207.47Cr 188.41Cr 356.59Cr 24TCr 2.48TCr 989.73Cr 13TCr 942.06Cr 922.08Cr 40TCr P/E 2027 *
15.5x
P/E 2028 * 13.4x
Enterprise Value 467.97Cr 573.41Cr 320.48Cr 287.41Cr 264.88Cr 240.55Cr 455.26Cr 30TCr 3.17TCr 1.26TCr 16TCr 1.2TCr 1.18TCr 51TCr EV / Sales 2027 *
0.33x
EV / Sales 2028 * 0.32x
Free-Float
90.8%
Yield 2027 *
5.39%
Yield 2028 * 5.9%
1 day-1.38%
1 week-0.23%
Current month+4.39%
1 month+12.75%
3 months-3.39%
6 months+0.05%
Current year-22.52%
1 week 20.96
Extreme 20.96
21.96
1 month 19.07
Extreme 19.07
21.96
Current year 18.45
Extreme 18.45
28.09
1 year 18.45
Extreme 18.45
29.5
3 years 18.45
Extreme 18.45
42.55
5 years 18.45
Extreme 18.45
46.75
10 years 16.05
Extreme 16.05
46.75
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Date Insider Type Main position Quantity % Market Cap. Importance
18/09/26 Buy

Director

27 0.0000%
18/09/26 Buy

Director

160 0.0001%
18/09/26 Buy

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%-0.23%-25.02%-42.47% 251.02Cr
+1.44%+1.63%+48.17%+139.63% 1,27600Cr
-0.47%+5.49%+49.03%+90.68% 68TCr
+0.20%+2.76%+34.37%+112.06% 52TCr
-0.58%+0.93%+38.41%+67.37% 39TCr
-0.48%+2.34%+70.66%+46.02% 36TCr
-1.18%-0.91%+27.82%+57.22% 31TCr
-0.03%-1.16%+2.94%+35.27% 29TCr
0.00%+0.86%+43.74%+74.04% 25TCr
+0.92%+2.03%+44.62%+125.07% 21TCr
Average -0.53%+1.98%+33.48%+70.49% 43TCr
Weighted average by Cap. -0.66%+2.51%+42.70%+96.47%

Financials

2027 *2028 *
Net sales 1.4TCr 1.72TCr 960.05Cr 860.97Cr 793.47Cr 720.6Cr 1.36TCr 90TCr 9.5TCr 3.79TCr 48TCr 3.6TCr 3.53TCr 1,52500Cr 1.46TCr 1.79TCr 1TCr 898.39Cr 827.96Cr 751.92Cr 1.42TCr 94TCr 9.91TCr 3.95TCr 50TCr 3.76TCr 3.68TCr 1,59100Cr
Net income 23Cr 28Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.46TCr 154.25Cr 61Cr 783.01Cr 58Cr 57Cr 2.48TCr 26Cr 32Cr 18Cr 16Cr 15Cr 14Cr 26Cr 1.69TCr 178.46Cr 71Cr 905.87Cr 68Cr 66Cr 2.86TCr
Net Debt 101.43Cr 124.28Cr 69Cr 62Cr 57Cr 52Cr 99Cr 6.51TCr 687.39Cr 273.88Cr 3.49TCr 260.68Cr 255.16Cr 11TCr 98Cr 119.55Cr 67Cr 60Cr 55Cr 50Cr 95Cr 6.26TCr 661.24Cr 263.46Cr 3.36TCr 250.77Cr 245.45Cr 11TCr
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
11/26/11 NZ$21.40 -1.38% 81,240
10/26/10 NZ$21.70 +3.33% 1,38,268
09/26/09 NZ$21.00 -2.05% 77,976
06/26/06 NZ$21.44 -1.11% 84,872
05/26/05 NZ$21.68 +0.93% 1,06,196
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.46AUD
Average target price
23.04AUD
Spread / Average Target
+31.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited